AssetMark Inc
DGX icon

AssetMark Inc’s Quest Diagnostics DGX Stock Holding History

AssetMark Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Sell
10,418
-140
-1% -$27.5K ﹤0.01% 931
2026
Q1 		$2.07M Buy
10,558
+579
+6% +$112K ﹤0.01% 884
2025
Q4 		$1.73M Buy
9,979
+191
+2% +$34.8K ﹤0.01% 888
2025
Q3 		$1.87M Buy
9,788
+1,001
+11% +$178K ﹤0.01% 828
2025
Q2 		$1.58M Buy
8,787
+1,975
+29% +$343K ﹤0.01% 815
2025
Q1 		$1.15M Buy
6,812
+450
+7% +$73.9K ﹤0.01% 842
2024
Q4 		$960K Buy
6,362
+239
+4% +$37.2K ﹤0.01% 855
2024
Q3 		$951K Buy
6,123
+162
+3% +$24.2K ﹤0.01% 787
2024
Q2 		$816K Buy
5,961
+376
+7% +$51.5K ﹤0.01% 802
2024
Q1 		$743K Sell
5,585
-203
-4% -$26.3K ﹤0.01% 773
2023
Q4 		$798K Buy
5,788
+699
+14% +$91.9K ﹤0.01% 721
2023
Q3 		$620K Buy
5,089
+1,224
+32% +$163K ﹤0.01% 716
2023
Q2 		$543K Buy
3,865
+160
+4% +$22.1K ﹤0.01% 717
2023
Q1 		$524K Buy
3,705
+131
+4% +$18.7K ﹤0.01% 706
2022
Q4 		$559K Buy
3,574
+215
+6% +$30.9K ﹤0.01% 687
2022
Q3 		$412K Buy
3,359
+43
+1% +$5.66K ﹤0.01% 682
2022
Q2 		$441K Sell
3,316
-164
-5% -$22.3K ﹤0.01% 643
2022
Q1 		$476K Sell
3,480
-399,171
-99% -$55.6M ﹤0.01% 623
2021
Q4 		$69.7M Buy
402,651
+398,651
+9,966% +$60.7M 0.29% 91
2021
Q3 		$581K Buy
4,000
+408
+11% +$59.7K ﹤0.01% 441
2021
Q2 		$474K Buy
3,592
+636
+22% +$83.3K ﹤0.01% 464
2021
Q1 		$379K Buy
2,956
+16
+0.5% +$1.97K ﹤0.01% 479
2020
Q4 		$350K Sell
2,940
-513
-15% -$62.5K ﹤0.01% 483
2020
Q3 		$395K Buy
3,453
+1,126
+48% +$133K ﹤0.01% 437
2020
Q2 		$265K Buy
2,327
+1,591
+216% +$169K ﹤0.01% 464
2020
Q1 		$59K Buy
736
+144
+24% +$14.9K ﹤0.01% 653
2019
Q4 		$63K Sell
592
-3
-0.5% -$313 ﹤0.01% 692
2019
Q3 		$64K Sell
595
-13
-2% -$1.33K ﹤0.01% 672
2019
Q2 		$62K Buy
608
+4
+0.7% +$384 ﹤0.01% 666
2019
Q1 		$54K Sell
604
-100
-14% -$8.66K ﹤0.01% 683
2018
Q4 		$59K Buy
704
+185
+36% +$17.3K ﹤0.01% 652
2018
Q3 		$56K Sell
519
-8
-2% -$877 ﹤0.01% 716
2018
Q2 		$58K Sell
527
-37
-7% -$3.85K ﹤0.01% 688
2018
Q1 		$57K Sell
564
-909
-62% -$93.1K ﹤0.01% 692
2017
Q4 		$145K Buy
1,473
+858
+140% +$81.3K ﹤0.01% 511
2017
Q3 		$58K Sell
615
-125
-17% -$13.3K ﹤0.01% 667
2017
Q2 		$82K Buy
740
+119
+19% +$12.6K ﹤0.01% 584
2017
Q1 		$61K Sell
621
-10,438
-94% -$995K ﹤0.01% 598
2016
Q4 		$1.02M Buy
11,059
+10,317
+1,390% +$889K 0.01% 266
2016
Q3 		$63K Buy
742
+287
+63% +$24.1K ﹤0.01% 570
2016
Q2 		$37K Sell
455
-477
-51% -$36.3K ﹤0.01% 676
2016
Q1 		$67K Buy
932
+46
+5% +$3.08K ﹤0.01% 511
2015
Q4 		$63K Buy
886
+820
+1,242% +$55.1K ﹤0.01% 571
2015
Q3 		$4K Buy
+66
New +$4.61K ﹤0.01% 585

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AssetMark Inc's DGX Position: Q2 2026 in Review

AssetMark Inc reduced its Quest Diagnostics (DGX) stake by 1.3% in Q2 2026, selling an estimated $27.5K and leaving 10,418 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #931.

AssetMark Inc first reported a position in DGX in Q3 2015 and has held it in 44 quarters since. The position peaked at $69.7M in Q4 2021. 444 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • AssetMark Inc held 10,418 shares of Quest Diagnostics worth $2.21M as of Q2 2026.
  • AssetMark Inc sold 140 Quest Diagnostics shares in Q2 2026, an estimated $27.5K.
  • Quest Diagnostics made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #931 holding.
  • AssetMark Inc first reported a position in Quest Diagnostics in Q3 2015 and has held it in 44 quarters since.
  • AssetMark Inc's Quest Diagnostics position peaked at $69.7M in Q4 2021.
  • 444 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.